查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1691702

豬疫苗市場 - 全球產業規模、佔有率、趨勢、機會和預測，按產品、類型、目標疾病、地區和競爭細分，2020-2030 年預測

Swine Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Type, By Target Disease, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球豬疫苗市場價值為 13.2 億美元，預計在預測期內將實現令人印象深刻的成長，到 2030 年的複合年成長率為 4.85%。全球豬疫苗市場是動物保健產業的重要領域，專注於預防和管理豬群疾病。豬疫苗對於確保養豬業中豬的健康和生產力起著至關重要的作用，而養豬業是全球肉類產業的重要組成部分。例如，根據《世界人口評論》的《2024年豬肉消費數據》，全球豬肉消費量為112.6萬噸，預計到2031年將增加至129萬噸。這種不斷成長的需求，尤其是在亞太地區、歐洲和北美，凸顯了對健康高產豬群的需求。為了維持供應和質量，養豬生產商優先透過有效的疫苗接種來預防疾病，並採用先進的生物安全措施來提高豬群的健康和效率，從而推動市場成長。

市場概況
預測期 2026-2030
2024 年市場規模 13.2 億美元
2030 年市場規模 17.4 億美元
2025-2030 年複合年成長率 4.85％
成長最快的領域 重組疫苗
最大的市場 亞太地區

主要市場促進因素

豬肉需求不斷成長

主要市場挑戰

新興疾病和病原體

主要市場趨勢

精準疫苗接種

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：顧客之聲

第5章：全球豬疫苗市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依產品（減毒活疫苗、DNA疫苗、去活化疫苗、重組疫苗、次單位疫苗）
    • 依類型（胸膜肺炎放線桿菌、豬瘟、口蹄疫、PEDV、豬圓環病毒 2 型、豬細小病毒、PRRS、偽狂犬病、豬流感）
    • 依目標疾病（關節炎、百日咳鼻炎、腹瀉、口蹄疫、豬圓環病毒相關疾病、豬生殖與呼吸症候群、偽狂犬病、豬流感）
    • 按地區
    • 按公司分類（2024）
  • 產品市場圖
    • 按產品
    • 按類型
    • 按目標疾病
    • 按地區

第6章：北美豬疫苗市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 加拿大
    • 墨西哥

第7章：歐洲豬疫苗市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 英國
    • 法國
    • 義大利
    • 西班牙

第 8 章：亞太豬疫苗市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 日本
    • 印度
    • 澳洲
    • 韓國

第9章：南美豬疫苗市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲豬疫苗市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 合併與收購
  • 產品發布

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章：競爭格局

  • Merck & Co Inc
  • Zoetis Inc
  • Boehringer Ingelheim GmbH
  • Elanco Animal Health Inc
  • Indian Immunologicals Ltd
  • Biogenesis Bago SA
  • Phibro Animal Health Corp
  • Laboratorios HIPRA SA
  • Virbac SA

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 18799

Global Swine Vaccines Market was valued at USD 1.32 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 4.85% through 2030. The global swine vaccines market is a vital segment of the animal health industry that focuses on preventing and managing diseases in swine populations. Swine vaccines play a crucial role in ensuring the health and productivity of pigs in the swine farming sector, which is a significant component of the global meat industry. For instance, according to the World Population Review's Pork Consumption Data 2024, global pork consumption stands at 112.6 kilotons and is expected to rise to 129 kilotons by 2031. This increasing demand, especially in Asia-Pacific, Europe, and North America, underscores the need for healthy and productive swine herds. To sustain supply and quality, pig producers are prioritizing disease prevention through effective vaccination, driving market growth as they adopt advanced biosecurity measures to enhance herd health and efficiency.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.32 Billion
Market Size 2030USD 1.74 Billion
CAGR 2025-20304.85%
Fastest Growing SegmentRecombinant Vaccines
Largest MarketAsia Pacific

Key Market Drivers

Rising Demand for Pork

The world's population is steadily increasing, and with it, the demand for protein-rich foods like pork is on the rise. As more people move to urban areas, their dietary preferences tend to shift towards meat-based diets. This urbanization trend amplifies the demand for pork products, leading to larger swine farming operations. To meet this burgeoning demand, farmers rely on swine vaccines to ensure the health and productivity of their herds.

Emerging markets in regions such as Asia, Latin America, and Africa are witnessing a rapid expansion of their middle-class populations. As incomes rise, so does the consumption of animal protein, including pork. This socio-economic shift is a major driver of increased demand for pork and, consequently, for swine vaccines. To meet the quality and safety standards demanded by this growing middle-class consumer base, swine farmers invest in disease prevention through vaccination.

Food security is a pressing concern in a world that needs to feed a growing population sustainably. Pork is an efficient source of protein, as pigs can convert feed into meat relatively quickly compared to other livestock. Ensuring the health and well-being of swine herds through vaccination is a key component of sustainable swine farming. Healthy pigs mean higher yields, reduced waste, and a more sustainable food supply chain.

Key Market Challenges

Emerging Diseases and Pathogens

The swine industry faces an ongoing threat from emerging diseases and evolving strains of existing pathogens. New diseases, such as African swine fever (ASF) and novel strains of influenza, can have devastating consequences for swine herds. Developing effective vaccines to combat these emerging threats is a constant challenge for vaccine manufacturers.

Key Market Trends

Precision Vaccination

One of the emerging trends in the swine vaccines market is precision vaccination. Traditional vaccines provide broad protection against a range of pathogens, but advances in vaccine technology now allow for more precise targeting of specific diseases. This trend helps swine farmers address unique disease challenges and reduce the potential for adverse reactions.

Key Market Players

  • Merck & Co Inc
  • Zoetis Inc
  • Boehringer Ingelheim GmbH
  • Elanco Animal Health Inc
  • Indian Immunologicals Ltd
  • Biogenesis Bago SA
  • Phibro Animal Health Corp
  • Laboratorios HIPRA SA
  • Virbac SA

Report Scope:

In this report, the Global Swine Vaccines Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Swine Vaccines Market, By Product:

  • Attenuated Live Vaccines
  • DNA Vaccines
  • Inactivated Vaccines
  • Recombinant Vaccines
  • Subunit Vaccines

Swine Vaccines Market, By Type:

  • Actinobacillus Pleuropneumoniae
  • Classical Swine Fever
  • Foot & Mouth Disease
  • PEDV
  • Porcine Circovirus Type 2
  • Porcine Parvovirus
  • PRRS
  • Pseudorabies
  • Swine Influenza

Swine Vaccines Market, By Target Disease:

  • Arthritis
  • Bordetella Rhinitis
  • Diarrhea
  • Foot & Mouth Disease
  • Porcine Circovirus Associated Disease
  • Porcine Reproductive & Respiratory Syndrome
  • Pseudorabies
  • Swine Influenza

Swine Vaccines Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Swine Vaccines Market.

Available Customizations:

Global Swine Vaccines market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Swine Vaccines Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines)
    • 5.2.2. By Type (Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease, PEDV, Porcine Circovirus Type 2, Porcine Parvovirus, PRRS, Pseudorabies, Swine Influenza)
    • 5.2.3. By Target Disease (Arthritis, Bordetella Rhinitis, Diarrhea, Foot & Mouth Disease, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, Pseudorabies, Swine Influenza)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Product Market Map
    • 5.3.1. By Product
    • 5.3.2. By Type
    • 5.3.3. By Target Disease
    • 5.3.4. By Region

6. North America Swine Vaccines Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines)
    • 6.2.2. By Type (Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease, PEDV, Porcine Circovirus Type 2, Porcine Parvovirus, PRRS, Pseudorabies, Swine Influenza)
    • 6.2.3. By Target Disease (Arthritis, Bordetella Rhinitis, Diarrhea, Foot & Mouth Disease, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, Pseudorabies, Swine Influenza)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Swine Vaccines Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By Target Disease
    • 6.3.2. Canada Swine Vaccines Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By Target Disease
    • 6.3.3. Mexico Swine Vaccines Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By Target Disease

7. Europe Swine Vaccines Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines)
    • 7.2.2. By Type (Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease, PEDV, Porcine Circovirus Type 2, Porcine Parvovirus, PRRS, Pseudorabies, Swine Influenza)
    • 7.2.3. By Target Disease (Arthritis, Bordetella Rhinitis, Diarrhea, Foot & Mouth Disease, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, Pseudorabies, Swine Influenza)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Swine Vaccines Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Target Disease
    • 7.3.2. United Kingdom Swine Vaccines Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Target Disease
    • 7.3.3. France Swine Vaccines Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Target Disease
    • 7.3.4. Italy Swine Vaccines Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By Target Disease
    • 7.3.5. Spain Swine Vaccines Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By Target Disease

8. Asia-Pacific Swine Vaccines Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines)
    • 8.2.2. By Type (Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease, PEDV, Porcine Circovirus Type 2, Porcine Parvovirus, PRRS, Pseudorabies, Swine Influenza)
    • 8.2.3. By Target Disease (Arthritis, Bordetella Rhinitis, Diarrhea, Foot & Mouth Disease, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, Pseudorabies, Swine Influenza)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Swine Vaccines Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Target Disease
    • 8.3.2. Japan Swine Vaccines Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Target Disease
    • 8.3.3. India Swine Vaccines Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Target Disease
    • 8.3.4. Australia Swine Vaccines Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By Target Disease
    • 8.3.5. South Korea Swine Vaccines Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By Target Disease

9. South America Swine Vaccines Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines)
    • 9.2.2. By Type (Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease, PEDV, Porcine Circovirus Type 2, Porcine Parvovirus, PRRS, Pseudorabies, Swine Influenza)
    • 9.2.3. By Target Disease (Arthritis, Bordetella Rhinitis, Diarrhea, Foot & Mouth Disease, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, Pseudorabies, Swine Influenza)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Swine Vaccines Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Target Disease
    • 9.3.2. Argentina Swine Vaccines Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Target Disease
    • 9.3.3. Colombia Swine Vaccines Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Target Disease

10. Middle East and Africa Swine Vaccines Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines)
    • 10.2.2. By Type (Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease, PEDV, Porcine Circovirus Type 2, Porcine Parvovirus, PRRS, Pseudorabies, Swine Influenza)
    • 10.2.3. By Target Disease (Arthritis, Bordetella Rhinitis, Diarrhea, Foot & Mouth Disease, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, Pseudorabies, Swine Influenza)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Swine Vaccines Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Target Disease
    • 10.3.2. Saudi Arabia Swine Vaccines Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Target Disease
    • 10.3.3. UAE Swine Vaccines Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By Target Disease
    • 10.3.4. Kuwait Swine Vaccines Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Product
        • 10.3.4.2.2. By Type
        • 10.3.4.2.3. By Target Disease

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Merck & Co Inc
    • 14.1.1. Business Overview
    • 14.1.2. Product Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Zoetis Inc
  • 14.3. Boehringer Ingelheim GmbH
  • 14.4. Elanco Animal Health Inc
  • 14.5. Indian Immunologicals Ltd
  • 14.6. Biogenesis Bago SA
  • 14.7. Phibro Animal Health Corp
  • 14.8. Laboratorios HIPRA SA
  • 14.9. Virbac SA

15. Strategic Recommendations

16. About Us & Disclaimer